Reduction of regional cerebral blood flow and cognitive impairment in patients with alzheimer’s disease: Evaluation of an observer-independent analytic approach

Dementia and Geriatric Cognitive Disorders

Volumn 8, Issue 2, 1997, Pages 98-104

  Hirsch, Christine ^a   Bartenstein, Peter ^a   Minoshima, Satoshi ^b   Mosch, Dagmar ^a   Willoch, Frode ^a   Buch, Katharina ^a   Schad, Daniel ^a   Schwaiger, Markus ^a   Kurz, Alexander ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer s disease; Cognitive dysfunction; Single photon emission computed tomography; Three dimensional display

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; FRONTAL LOBE; HUMAN; LANGUAGE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

EID: 0031002188     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106613     Document Type: Article

References (34)

1. O'Mahony D. Coffey J. Murphy J. O'Hare N, Hamilton D, Freyne P. Walsh JB. Coakley D: The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. J NuclMed 1994:35:1450-1455.
2. Messa C, Perani D, Lucignani G, Zenorini A, Zito F, Rizzo G, Grassi F, DelSole A, Franceschi M, Giraldi MC: High-resolution technictium-99-m-HMPAO SPECT in patients with probable Alzheimer's disease: Comparison with fluorine-1 S-FDG-PET. J Nucl Med 1994; 35:210-216.
3. Brooks DJ: PET: its clinical role in neurology. J Neurol Neurosurg Psychiatry 1991:54:1-5.
4. Heiss WD. Szelies B. Kessler J. Herholz K: Abnormalities of energy metabolism in Alzheimer's disease studied with PET. Ann NY AcadSci 1991:640:65-71.
5. Salmon E. Sadzot B. Maquet P. Degueldre C. Lemairc C. Rigo P. Comar D. Franck G: Differential diagnosis of Alzheimer's disease with PET. J Nucl Med 1994;35:391-398.
6. Montaldi D. Brooks DN. McColl JH. Wyper D. Patterson J, Barron E, McCulloch J: Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1990:53:33-38.
7. Burns A, Philpot MP, Costa DC, Ell PJ, Levy R: The investigation of Alzheimer's disease with single-photon emission tomography. J Neurol Neurosurg Psychiatry 1989:52:248-253.
8. Osimani A. Ichise M. Chung DG. Pogue JM. Freedman M: SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment. Can J Neurol Sci 1994:21: 104-111.
9. Braak H. Braak E: Ncuropathological staging of Alzheimer-related changes. Acta Ncuropathol 1991:82:239-259.
10. Knapp MJ. Knopman DS. Solomon PR. Pendlebury WW, Davis CS, Gracon SI: A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994:271:985-991.
11. Holman BL, Devous MD Sr: Functional brain SPECT: The emergence of a powerful clinical method. J Nucl Med 1992;33:1888-1904.
12. Jobst KA. Hindley NJ. King E. Smith AD: The diagnosis of Alzheimer's disease: A question of image? J Clin Psychiatry 1994;55(suppl):22-31.
13. McKhann G, Drachman D, Folstein M. Katz-man R. Price D. Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
14. Folstein MF. Folstein SF. McHugh PR: 'Mini Mental State': A practical method for grading the cognitive state of patients for the clinician. J PsychiatrRes 1975:12:189-198.
15. Roth ET. Mountjoy CQ. Huppert FA. Hendrie H. Verma S. Goddard A: CAMDEX: A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychol 1986:149:698-709.
16. Vollet B. Bartenstein P. Zimmermann Z. Schober O: Quantitativer und qualitativer Vergleich von SPECT-Systemen zur Himszinligraphie. Nuklearmedizin I993:32:A23.
17. Chang LT: A method for attenuation correction in radionuclide computed tomography. IEEE NS 1978:25:638-639.
18. Minoshima S. Berger KL. Lee KS; Mintun MA: An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med 1992:33:1579-1585.
19. Minoshima S. Koeppe RA. Mintun MA. Berger KL. Taylor SF. Frey KA. Kulil DE: Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med 1993:34:322-329.
20. Minoshima S. Koeppe RA, Frey KA, Ishihara M. Kuhl DE: Stereotactic PET atlas of the human brain: Aid for visual interpretation of functional brain images. J Nucl Med 1994:35: 949-954.
21. Minoshima S, Koeppe RA, Frey KA, Kuhl DE: Anatomic standardization: Linear scaling and nonlinear warping of functional brain images. J NuclMed 1994:35:1528-1537.
22. Talairach J. Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. New York. Thieme. 1988.
23. Minoshima S. Frey KA, Koeppe RA. Foster NL, Kuhl DE: A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995:36:1238-1248.
24. Akiyama H, Harrop R, McGeer PL, Peppard R, McGeer EG: Crossed cerebellar diaschisis and uncrossed basal ganglia and thalamic diaschisis in Alzheimer’s disease. Neurology 1989; 39 541-548.
25. Mazziotta JC. Frackowiak RSJ. Phelps ME: The use of positron emission tomography in the clinical assessment of dementia. Semin NuclMed 1992;22:233-246.
26. Links MJ. Devous MD Sr: Detection and comparison of patterns in images. J Nucl Med 1994:35:16-17.
27. Hashikawa K, Matsuntoto M, Moriwaki H, Oku N, Okazaki Y, Seike Y, Uchara T, Tanabe H, Ohie Y, Kamade T, Nishimura T: Three-dimensional display of surface cortical perfusion by SPECT: Application in assessing Alzheimer's disease. J Nucl Med 1995:36:690-696.
28. Lantos P: Ageing and Dementias: in Weller R (ed): Nervous System. Muscle and Eyes. Edinburgh. Churchill Livingstone. 1990.
29. O'Brien J, Eagger S. Syed GMS, Sahakian BJ, Levy R: A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992:55: 1182-1187.
30. Kuhl DE, Phelps ME, Kowell AP, Metier EJ, Selin C, Winter J: Effects of stroke on local cerebral metabolism and perfusion: Mapping by emission computed tomography of 18-FDG and 13-NH3. Ann Neurol 1980:8:47-60.
31. Minoshima S, Frey KA, Foster NL, Kuhl DE: Preserved pontine glucose metabolism in Alzheimer's disease: A reference region for functional brain image (PET) analysis. J Compul Assist Tornogr 1995; 19:541-547.
32. Kushner M. Tobin M. Alavi A. Chawluk J, Rosen M. Fazekas F, Alavi J, Reivich M: Cerebellar glucose consumption in normal and pathologic stales using fluorine-FDG and PET. J Nucl Med 1987;28:1667-1670.
33. 1231-IBZM bei cxtrapyramidalcn Erkrankungen. Nuklcar-mcdizin 1994;33:184-188.
34. Mielke R, Grond M, Herholz K, Kessler J, Heiss WD: Age-dependent changes of the metabolic pattern in patients with Alzheimer's disease; in Maurer K (ed): Imaging of the Brain in Psychiatry and Related Fields. Berlin, Springer, 1993. pp 171-176.